Browsing by Sponsor/Funder Vasculitis UK
Showing results 1 to 7 of 7
| Issue Date | Title | Author(s) |
| 1-Mar-2017 | ANCA-ASSOCIATED VASCULITIS PATIENTS EXHIBIT REDUCED SERUM LEVELS OF SOLUBLE RAGE (SRAGE) | Brunini, F; Cao, JJL; Dudhiya, F; McAdoo, S; Page, TH, et al |
| 20-Jan-2017 | Is There a Role for TNFα Blockade In ANCA-Associated Vasculitis and Glomerulonephritis? | McAdoo, SP; Pusey, CD; |
| 12-May-2017 | Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. | McAdoo, SP; Tanna, A; Hrušková, Z; Holm, L; Weiner, M, et al |
| 1-Jun-2020 | Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model | McAdoo, S; Prendecki, M; Tanna, A; Bhatt, T; Bhangal, G, et al |
| 30-Jul-2016 | Spleen tyrosine kinase: a crucial player and potential therapeutic target in renal disease | Tam, FWK; Ma, TK-W; Mcadoo, SP; McAdoo, SPM; Ma, TK-M, et al |
| 20-Jan-2017 | Targeting the tyrosine kinase signaling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond | Ma, TK-W; McAdoo, SP; Tam, FWK; , et al |
| Sep-2018 | The role of the spleen tyrosine kinase pathway in driving inflammation in IgA nephropathy | Tam, FWK; McAdoo, S; , et al |